The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Insurers Retreat From Medicare Advantage as Costs Climb

Several insurers are pulling out of Medicare Advantage markets or cutting back their plan offerings, a shift Becker's Hospital Review reports has accelerated over the past few years. The common thread is money: medical costs are climbing faster than expected, and federal cost-containment efforts have chipped away at the program's financial viability for carriers.

Star ratings are a central fault line. How the ratings are calculated determines which plans qualify for lucrative bonus payments, and ongoing disputes over that methodology have made revenue harder to predict. Layer on scrutiny of prior authorization denials and reimbursement pressure, and some insurers have decided certain markets are no longer worth serving, according to Becker's.

In practice, exits and plan reductions mean seniors in affected areas face fewer choices, potential coverage disruptions, and the hassle of switching plans. For hospitals and medical groups, a thinner MA field can reshape payer mix and contracting leverage. The retreat signals that the years of aggressive MA expansion are giving way to a more selective, margin-focused era.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.